DK3539545T3 - Krystallinsk form af gnrh-receptorantagonist og fremgangsmåde til fremstilling deraf - Google Patents
Krystallinsk form af gnrh-receptorantagonist og fremgangsmåde til fremstilling deraf Download PDFInfo
- Publication number
- DK3539545T3 DK3539545T3 DK17869463.4T DK17869463T DK3539545T3 DK 3539545 T3 DK3539545 T3 DK 3539545T3 DK 17869463 T DK17869463 T DK 17869463T DK 3539545 T3 DK3539545 T3 DK 3539545T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparing
- receptor antagonist
- gnrh receptor
- crystallic
- crystallic form
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/28—Oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610999743 | 2016-11-14 | ||
| PCT/CN2017/110685 WO2018086608A1 (zh) | 2016-11-14 | 2017-11-13 | 一种GnRH受体拮抗剂的结晶形式及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3539545T3 true DK3539545T3 (da) | 2021-09-27 |
Family
ID=62109467
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17869463.4T DK3539545T3 (da) | 2016-11-14 | 2017-11-13 | Krystallinsk form af gnrh-receptorantagonist og fremgangsmåde til fremstilling deraf |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10787451B2 (da) |
| EP (1) | EP3539545B1 (da) |
| JP (1) | JP2019535712A (da) |
| KR (1) | KR102516017B1 (da) |
| CN (1) | CN108778282B (da) |
| AU (1) | AU2017357332B2 (da) |
| BR (1) | BR112019009455A2 (da) |
| CA (1) | CA3040026A1 (da) |
| DK (1) | DK3539545T3 (da) |
| ES (1) | ES2887018T3 (da) |
| HR (1) | HRP20211379T1 (da) |
| HU (1) | HUE055891T2 (da) |
| PL (1) | PL3539545T3 (da) |
| PT (1) | PT3539545T (da) |
| TW (1) | TWI774704B (da) |
| WO (1) | WO2018086608A1 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202111907UA (en) * | 2019-04-30 | 2021-11-29 | Beijing Tide Pharmaceutical Co Ltd | Solid form of diaminopyrimidine compound or hydrate thereof, preparation method therefor, and application thereof |
| CN117203209A (zh) * | 2021-04-02 | 2023-12-08 | 江苏恒瑞医药股份有限公司 | 一种GnRH受体拮抗剂的结晶形式及其制备方法 |
| CN117769424A (zh) * | 2021-08-30 | 2024-03-26 | 江苏恒瑞医药股份有限公司 | 一种GnRH受体拮抗剂的结晶工艺 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008533025A (ja) | 2005-03-07 | 2008-08-21 | ワイス | キノキサリンジヒドロハライド二水和物およびそのための合成方法 |
| JPWO2010026993A1 (ja) | 2008-09-03 | 2012-02-02 | 武田薬品工業株式会社 | 製剤における吸収性改善方法および吸収性が改善された製剤 |
| TW201130854A (en) | 2009-12-22 | 2011-09-16 | Bayer Schering Pharma Ag | Pyridinone derivatives and pharmaceutical compositions thereof |
| WO2012175514A1 (en) | 2011-06-21 | 2012-12-27 | Bayer Intellectual Property Gmbh | Pyridinone derivatives and pharmaceutical compositions thereof |
| UY35058A (es) * | 2012-09-28 | 2014-04-30 | Takeda Pharmaceutical | Método de producción de derivado de tienopirimidina |
| SI3064498T1 (sl) * | 2013-10-30 | 2019-11-29 | Shanghai hengrui pharmaceutical co ltd | Derivati pirazolopirimidona ali pirolotriazona, postopki priprave le-teh in farmacevtske uporabe le-teh |
| CN104788435A (zh) * | 2014-01-16 | 2015-07-22 | 江苏恒瑞医药股份有限公司 | 一种蛋白酪氨酸激酶抑制剂的二苯磺酸盐的i型结晶 |
-
2017
- 2017-11-13 WO PCT/CN2017/110685 patent/WO2018086608A1/zh active Application Filing
- 2017-11-13 JP JP2019525785A patent/JP2019535712A/ja active Pending
- 2017-11-13 ES ES17869463T patent/ES2887018T3/es active Active
- 2017-11-13 BR BR112019009455A patent/BR112019009455A2/pt active Search and Examination
- 2017-11-13 CA CA3040026A patent/CA3040026A1/en active Pending
- 2017-11-13 KR KR1020197015658A patent/KR102516017B1/ko active IP Right Grant
- 2017-11-13 TW TW106139177A patent/TWI774704B/zh not_active IP Right Cessation
- 2017-11-13 PL PL17869463T patent/PL3539545T3/pl unknown
- 2017-11-13 CN CN201780017902.8A patent/CN108778282B/zh active Active
- 2017-11-13 AU AU2017357332A patent/AU2017357332B2/en not_active Ceased
- 2017-11-13 PT PT178694634T patent/PT3539545T/pt unknown
- 2017-11-13 HU HUE17869463A patent/HUE055891T2/hu unknown
- 2017-11-13 DK DK17869463.4T patent/DK3539545T3/da active
- 2017-11-13 EP EP17869463.4A patent/EP3539545B1/en active Active
- 2017-11-13 US US16/348,932 patent/US10787451B2/en active Active
-
2021
- 2021-08-30 HR HRP20211379TT patent/HRP20211379T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20190080915A (ko) | 2019-07-08 |
| JP2019535712A (ja) | 2019-12-12 |
| CN108778282B (zh) | 2021-07-27 |
| BR112019009455A2 (pt) | 2019-07-30 |
| AU2017357332A1 (en) | 2019-05-09 |
| KR102516017B1 (ko) | 2023-03-30 |
| PT3539545T (pt) | 2021-09-06 |
| US20190276455A1 (en) | 2019-09-12 |
| ES2887018T3 (es) | 2021-12-21 |
| TW201817734A (zh) | 2018-05-16 |
| TWI774704B (zh) | 2022-08-21 |
| AU2017357332B2 (en) | 2021-10-28 |
| CA3040026A1 (en) | 2018-05-17 |
| WO2018086608A1 (zh) | 2018-05-17 |
| US10787451B2 (en) | 2020-09-29 |
| EP3539545A4 (en) | 2020-07-01 |
| EP3539545A1 (en) | 2019-09-18 |
| HUE055891T2 (hu) | 2022-01-28 |
| HRP20211379T1 (hr) | 2021-12-10 |
| PL3539545T3 (pl) | 2022-01-10 |
| CN108778282A (zh) | 2018-11-09 |
| EP3539545B1 (en) | 2021-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3660004T3 (da) | Forbindelser og fremgangsmåder til målrettet degradering af androgenreceptor | |
| DK3298043T3 (da) | SIRP-polypeptidsammensætninger og fremgangsmåder til anvendelse | |
| DK3227310T3 (da) | Heterobifunktionelle inhibitorer af e-selektiner og cxcr4-kemokin-receptorer | |
| DK3294865T3 (da) | Fremgangsmåder til fremstilling af epimeraser og benzylisoquinolinalkaloider | |
| DK3393655T3 (da) | Fenfluramin-sammensætninger og fremgangsmåder til fremstilling af samme | |
| DK3394065T3 (da) | Tetrahydropyranyl-amino-pyrrolopyrimidinon og fremgangsmåder til anvendelse deraf | |
| DK3473621T3 (da) | Fremgangsmåde til fremstilling af diphenylmethan-derivat | |
| DK3280710T3 (da) | Fremgangsmåde til fremstilling af androgenreceptorantagonister og mellemprodukter deraf | |
| DK3280839T3 (da) | Indretning til fremføring og spredning af stofstykker | |
| DK3180290T3 (da) | Fremgangsmåde til ekstraktion og separation af sjældne jordarter | |
| DK3349772T3 (da) | Fremgangsmåde til fremstilling af urteekstrakter | |
| DK3389636T3 (da) | Sammensætninger og fremgangsmåder til fremstilling af proteinmikropartikler | |
| DK3368578T3 (da) | Anti-HtrA1-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3487443T3 (da) | Fremgangsmåde til opmåling af en implantat-implantat-situation | |
| DK3574135T3 (da) | Fremgangsmåde og formulering til fremstilling af ligninfibre | |
| DK3380456T3 (da) | Kompleks af angiotensin receptor antagonist og neutral endopeptidase inhibitor | |
| DK3218351T3 (da) | Fremgangsmåde til fremstilling, isolering og oprensning af farmaceutisk anvendelige former af ahu-377 | |
| DK3472338T3 (da) | Midler og fremgangsmåder til at modifikation af flere alleler | |
| DK3630772T3 (da) | Fremgangsmåder til fremstilling og anvendelse af pde9-hæmmere | |
| DK3495352T3 (da) | Krystalformer af en androgenreceptorantagonist, fremgangsmåde til fremstilling og anvendelse deraf | |
| DK3441381T3 (da) | Fremgangsmåde til fremstilling af methanol og indretning til fremstilling af methanol | |
| DK3356386T3 (da) | Fremgangsmåde til behandling af melanocortin-4 receptorbane-associerede lidelser | |
| DK3072560T3 (da) | Trampolinsystemer og fremgangsmåder til fremstilling og anvendelse deraf | |
| DK3347342T3 (da) | Fremgangsmåde til fremstilling af biguanidin-salte og s-triaziner | |
| DK3297631T3 (da) | NK-1/NK-3-receptorantagonist til behandling af hedeture |